Zydus Wellness (NSE:ZYDUSWELL) has been performing well on the share market, with its share price rising by 15% over the past three months. As most people know, fundamentals are what drive market price movements in the long term, so we decided to look at the company’s key financial indicators today to determine if they have had any influence on the recent price movement. In this article, we decided to focus on Zydus Wellness’ ROE.
ROE or return on equity is a tool that helps assess how effectively a company can generate profits on the investment it received from its shareholders. In simple terms, it is used to assess a company’s profitability on its equity capital.
Check out our latest analysis for Zydus Wellness
How to Calculate Return on Equity?
of Return on Equity Formula teeth:
Return on Equity = Net Income (from continuing operations) / Shareholders’ Equity
So, based on the above formula, Zydus Wellness’s ROE is:
5.0% = ₹2.7B ÷ ₹5.4B (Based on the trailing twelve months to March 2024).
The “return” refers to the yearly profit. One way to conceptualize this is that for every rupee of shareholders’ capital, the company made rupees of 0.05 in profit.
What is the relationship between ROE and profit growth?
We’ve already seen that ROE serves as an efficient profit-generating indicator to predict a company’s future earnings. Based on how much of its profits a company chooses to reinvest or “retain”, we can evaluate a company’s future profit-generating ability. Generally, all else being equal, companies with higher return on equity and profit retention tend to have higher growth rates than companies that don’t have these attributes.
Zydus Wellness’s revenue growth and 5.0% ROE
Zydus Wellness’s ROE is hard to call outstanding in itself. It is quite low compared to the industry average of 11%. However, it is definitely positive that Zydus Wellness has achieved moderate net income growth of 17% over the past five years. Therefore, the earnings growth is probably due to other factors. For example, the company’s management could have made good strategic decisions, or the company’s dividend payout ratio could be low.
As a next step, we compared Zydus Wellness’s net income growth with the industry and found that the company’s growth rate was similar compared to the average industry growth rate of 16% during the same period.
The metric for valuing a company is heavily tied to earnings growth. Investors need to see if the expected growth or decline in earnings, in either case, is factored into the price. Doing so helps them determine if the stock’s future is promising or ominous. Is Zydus Wellness fairly valued relative to other companies? The following three valuation metrics may help you decide:
Is Zydus Wellness making good use of its retained earnings?
Zydus Wellness has a low three-year median dividend payout ratio of 11%, meaning the company is retaining the remaining 89% of its profits, suggesting that management is reinvesting most of its profits into growing the business.
Additionally, Zydus Wellness has been paying dividends for at least 10 years, which indicates the company is committed to sharing profits with shareholders. Existing analysts’ forecasts indicate that the company’s dividend payout ratio is expected to decline to 5.4% over the next three years. The decline in the dividend payout ratio explains the fact that the company’s ROE is expected to rise to 8.0% over the same period.
Conclusion
Overall, there seem to be positives in Zydus Wellness’s business. Although its profit margins are low, the company reinvests a sizeable portion of its profits back into the business, which no doubt contributes to its strong earnings growth. We looked into current analyst forecasts and found that analysts expect the company to continue its recent growth trends. Are these analyst forecasts based on industry-wide expectations, or on the company’s fundamentals? Click here to be taken to the company’s analyst forecasts page.
Valuation is complicated, but we can help make it simple.
To find out if Zydus Wellness is overrated or underrated, take a look at our comprehensive analysis. Fair value estimates, risks and warnings, dividends, insider trading, financial strength.
View your free analysis
Have feedback about this article? Concerns about the content? contact Please contact us directly. Or email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We use only unbiased methodologies to provide commentary based on historical data and analyst forecasts, and our articles are not intended as financial advice. It is not a recommendation to buy or sell stocks, and does not take into account your objectives, or your financial situation. We seek to provide long-term focused analysis driven by fundamental data. Note that our analysis may not take into account the latest price sensitive company announcements or qualitative material. Simply Wall St has no position in any of the stocks mentioned.
